|
1
|
Grozovsky R, Giannini S, Falet H and
Hoffmeister KM: Regulating billions of blood platelets: Glycans and
beyond. Blood. 126:1877–1884. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hattori H and Ishihara M: Feasibility of
improving platelet-rich plasma therapy by using chitosan with high
platelet activation ability. Exp Ther Med. 13:1176–1180. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ed Rainger G, Chimen M, Harrison MJ, Yates
CM, Harrison P, Watson SP, Lordkipanidzé M and Nash GB: The role of
platelets in the recruitment of leukocytes during vascular disease.
Platelets. 26:507–520. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gibbins JM: Platelet adhesion signalling
and the regulation of thrombus formation. J Cell Sci.
117:3415–3425. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grozovsky R, Giannini S, Falet H and
Hoffmeister KM: Novel mechanisms of platelet clearance and
thrombopoietin regulation. Curr Opin Hematol. 22:445–451. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kurosawa Y, Nirengi S, Homma T, Esaki K,
Ohta M, Clark JF and Hamaoka T: A single-dose of oral nattokinase
potentiates thrombolysis and anti-coagulation profiles. Sci Rep.
5:116012015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie J, Ma J, Huang Q, Yue C and Pei F:
Comparison of enoxaparin and rivaroxaban in balance of
anti-fibrinolysis and anticoagulation following primary total knee
replacement: A pilot study. Med Sci Monit. 23:704–711. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen Z, Chen B, Yao XQ, Gui BS, Ou Y and
Ouyang JM: Anticoagulation of diethyl citrate and its comparison
with sodium citrate in an animal model. Blood Purif. 33:30–36.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yeung J, Tourdot BE, Fernandez-Perez P,
Vesci J, Ren J, Smyrniotis CJ, Luci DK, Jadhav A, Simeonov A,
Maloney DJ, et al: Platelet 12-LOX is essential for
FcgammaRIIa-mediated platelet activation. Blood. 124:2271–2279.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Violi F and Pignatelli P: Platelet NOX, a
novel target for anti-thrombotic treatment. Thromb Haemost.
111:817–823. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dütting S, Bender M and Nieswandt B:
Platelet GPVI. A target for antithrombotic therapy?! Trends
Pharmacol Sci. 33:583–590. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsuji M, Ezumi Y, Arai M and Takayama H: A
novel association of Fc receptor gamma-chain with glycoprotein VI
and their co-expression as a collagen receptor in human platelets.
J Biol Chem. 272:23528–23531. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Suzuki-Inoue K, Fuller GL, García A, Eble
JA, Pöhlmann S, Inoue O, Gartner TK, Hughan SC, Pearce AC, Laing
GD, et al: A novel Syk-dependent mechanism of platelet activation
by the C-type lectin receptor CLEC-2. Blood. 107:542–549. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rosenfeld SI, Looney RJ, Leddy JP, Phipps
DC, Abraham GN and Anderson CL: Human platelet Fc receptor for
immunoglobulin G. Identification as a 40,000-molecular-weight
membrane protein shared by monocytes. J Clin Invest. 76:2317–2322.
1985. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhi H, Rauova L, Hayes V, Gao C, Boylan B,
Newman DK, McKenzie SE, Cooley BC, Poncz M and Newman PJ:
Cooperative integrin/ITAM signaling in platelets enhances thrombus
formation in vitro and in vivo. Blood. 121:1858–1867. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suriano AR, Sanford AN, Kim N, Oh M,
Kennedy S, Henderson MJ, Dietzmann K and Sullivan KE: GCF2/LRRFIP1
represses tumor necrosis factor alpha expression. Mol Cell Biol.
25:9073–9081. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Santiago FS and Khachigian LM: Ets-1
stimulates platelet-derived growth factor A-chain gene
transcription and vascular smooth muscle cell growth via
cooperative interactions with Sp1. Circ Res. 95:479–487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goodall AH, Burns P, Salles I, Macaulay
IC, Jones CI, Ardissino D, de Bono B, Bray SL, Deckmyn H, Dudbridge
F, et al: Transcription profiling in human platelets reveals
LRRFIP1 as a novel protein regulating platelet function. Blood.
116:4646–4656. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Burns P, Gusnanto A, Macaulay IC, Rankin
A, Tom B, Langford CF, Dudbridge F, Ouwehand WH and Watkins NA;
Bloodomics Consortium, : Identification of variation in the
platelet transcriptome associated with glycoprotein 6 haplotype.
Platelets. 19:258–267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fong KS and de Couet HG: Novel proteins
interacting with the leucine-rich repeat domain of human
flightless-I identified by the yeast two-hybrid system. Genomics.
58:146–157. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jones-Bolin S: Guidelines for the care and
use of laboratory animals in biomedical research. Curr Protoc
Pharmacol Appendix 4. Appendix 4B. 2012. View Article : Google Scholar
|
|
22
|
Dennis MB Jr: Humane endpoints for
genetically engineered animal models. ILAR J. 41:94–98. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Langer HF, Choi EY, Zhou H, Schleicher R,
Chung KJ, Tang Z, Gobel K, Bdeir K, Chatzigeorgiou A, Wong C, et
al: Platelets contribute to the pathogenesis of experimental
autoimmune encephalomyelitis. Circ Res. 110:1202–1210. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sorrentino S, Studt JD, Medalia O and
Tanuj Sapra K: Roll, adhere, spread and contract: Structural
mechanics of platelet function. Eur J Cell Biol. 94:129–138. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ding C, Zhang J, Li R, Wang J, Hu Y, Chen
Y, Li X and Xu Y: Investigation of standardized administration of
anti-platelet drugs and its effect on the prognosis of patients
with coronary heart disease. Exp Ther Med. 14:3207–3212. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Breet NJ, van Werkum JW, Bouman HJ, Kelder
JC, Ruven HJ, Bal ET, Deneer VH, Harmsze AM, van der Heyden JA,
Rensing BJ, et al: Comparison of platelet function tests in
predicting clinical outcome in patients undergoing coronary stent
implantation. JAMA. 303:754–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu YT and Yin HL: Identification of the
binding partners for flightless I, A novel protein bridging the
leucine-rich repeat and the gelsolin superfamilies. J Biol Chem.
273:7920–7927. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yin X, Wu S, Wang Z, Wang Y, Du Q and Wang
A: Anti-thrombosis effect of LRRFIP1 shRNA lentivirus in a mouse
model of deep vein thrombosis. Thromb Res. 132:127–131. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bhoria P, Varma N, Malhotra P, Varma S and
Luthra-Guptasarma M: Immunodiagnosis of platelet activation in
immune thrombocytopenia through scFv antibodies cognate to
activated IIb3 integrins. MAbs. 7:1212–1220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fullard JF: The role of the platelet
glycoprotein IIb/IIIa in thrombosis and haemostasis. Curr Pharm
Des. 10:1567–1576. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bennett JS: Structure and function of the
platelet integrin alphaIIbbeta3. J Clin Invest. 115:3363–3369.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen P, Sun CX and Liu JN: A novel
anti-platelet monoclonal antibody (3C7) specific for the complex of
integrin alpha IIb beta3 inhibits platelet aggregation and
adhesion. J Biol Chem. 280:25403–25408. 2005. View Article : Google Scholar : PubMed/NCBI
|
